Yahoo News: Cancer

Insurance, income, education tied to survival after lung cancer surgery

Fri, 11/07/2014 - 21:36
By Kathryn Doyle (Reuters Health) – - How long patients survive after surgery to remove lung cancer may depend on factors like insurance, income and education, according to a new study. While the stage of the cancer is a more important influence on patient outcomes, the study’s senior author said understanding all of the factors tied to survival can identify groups of people who need more ...

Common Myths About Skin Cancer Debunked

Thu, 11/06/2014 - 14:00
Shannon Doan-Duff was a classic skin cancer candidate. Red hair, blue eyes, skin so pale she compares it to raw chicken, and lots of freckles.

Colon cancer could surge among young

Wed, 11/05/2014 - 22:35
Colon cancer among people under 34 may nearly double over the next 15 years, raising new concerns about how to fight one of the most common and deadly cancers, researchers said Wednesday. The rise in incidence in the younger population -- blamed on lifestyle choices -- goes against a long-running decline in colon cancer among people over 50.

One in 10 US women miss cervical cancer screenings

Wed, 11/05/2014 - 19:41
Eight million US women have not been screened in the last five years for cervical cancer, even though regular checkups can help prevent the fatal disease, US health authorities said Wednesday. About one in 10 women, or 11.4 percent, aged 21 to 65 have gone years without screening, said the report by the US Centers for Disease Control and Prevention based on national registry data from 2007 to ...

Glaxo scientists work to rebuild cancer line-up, funding uncertain

Wed, 11/05/2014 - 19:18
By Ransdell Pierson PHILADELPHIA (Reuters) - When GlaxoSmithKline agreed to sell its cancer drugs to Novartis in April, investors saw it as the death knell for an oncology business that languished well behind those of rivals. But the British drugmaker has not thrown in the towel completely and a tiny group of researchers experimenting with new treatments still believe they can find winners. "If ...

California hospital explores genetics-aided cancer treatment

Wed, 11/05/2014 - 18:37
By Christina Farr SAN FRANCISCO (Reuters) - A major California university hospital is exploring ways to gather and use genetic information gathered from cancer patients, hoping to break new ground in a fledgling field of genomic medicine. The University of California San Francisco said in an interview it is working on a new project with Silicon Valley start-up Syapse. Using Syapse's technology ...

Navigating Genetic Testing in an Uncertain Landscape (Op-Ed)

Tue, 11/04/2014 - 22:36
Genetic testing can tell you whether or not you are at a high risk for a disease like cancer, and then allow you to prevent it — yet such results often lead to a quandary for both patients and doctors.   There are multiple genes associated with cancer. Doctors often order genetic tests for patients with breast cancer or for those who are at high risk. BRCA 1 and BRCA 2 genes have been the most ...

AstraZeneca's olaparib may also work in prostate cancer: expert

Tue, 11/04/2014 - 17:07
LONDON (Reuters) - AstraZeneca's new cancer drug olaparib, which won a green light from European regulators last month for inherited ovarian cancer, could also be used much more widely to treat prostate cancer, according to a leading oncologist. Johann de Bono, professor of experimental cancer therapeutics at the Institute of Cancer Research in London, told a conference on Tuesday the drug had ...

10 Questions to Ask Your Doctor About Prostate Cancer

Tue, 11/04/2014 - 14:58
When you're diagnosed with prostate cancer, be proactive.

Amgen ovarian cancer drug fails to improve overall survival

Tue, 11/04/2014 - 14:51
(Reuters) - Amgen Inc said its experimental ovarian cancer drug did not show statistically significant improvement in overall survival rate in a late-stage trial. Patients given the drug, trebananib, along with a chemotherapy agent paclitaxel, experienced overall survival of 19.3 months, compared with 18.3 months for the placebo group. Statistically significant improvement in overall survival ...

AstraZeneca strengthens cancer business with new deals

Tue, 11/04/2014 - 08:01
LONDON (Reuters) - AstraZeneca moved to strengthen its core oncology business on Tuesday with three deals designed to expand the British drugmaker's reach in treating tumors. The collaborations include an agreement to buy Definiens, a private company that has developed a way of unlocking information from cancer tissue samples, for an initial $150 million, and two alliances to test novel drug ...

Newcastle's Gutierrez gets cancer all-clear

Mon, 11/03/2014 - 22:45
London (AFP) - Newcastle winger Jonas Gutierrez on Monday revealed he has been given the all-clear from cancer.

High triglycerides linked with prostate cancer recurrence

Mon, 11/03/2014 - 21:16
By Ronnie Cohen NEW YORK (Reuters Health) - A new study has linked high triglyceride levels with biochemical recurrence of prostate cancer. Among men who had surgery for prostate cancer, those with elevated triglyceride levels before surgery were 35% more likely to show signs of a cancer recurrence than men with normal preoperative levels. The study reinforces the benefits of maintaining a ...

No increased risk of cancer death with celiac disease

Mon, 11/03/2014 - 18:53
By Kathryn Doyle (Reuters Health) - By 10 years after a diagnosis of celiac disease, people with the condition are no more likely to die from cancer or cardiovascular disease than the general population, according to a new study. People with celiac disease were, in fact, slightly less likely to die of cardiovascular disease than others in the new study. When people with celiac disease, a ...

7 Innovations in Cancer Therapy

Mon, 11/03/2014 - 15:17
What to expect in cancer care

Terminally ill US woman kills herself

Mon, 11/03/2014 - 02:56
A young American woman with terminal cancer has committed suicide, following promises to do so that had triggered shock and controversy over the right to die. Brittany Maynard, a 29-year-old brain cancer sufferer, made headlines earlier this month when a video of her making her suicide threat went viral and was seen by millions of Web users. "Goodbye to all my dear friends and family that I love ...

Google's Cancer-Detecting Nanoparticles: Are There Drawbacks?

Thu, 10/30/2014 - 23:44
Google is developing nanoparticles that the company hopes will catch early signs of diseases such as cancer, but are there potential drawbacks to the technology? The microscopic particles would be designed to bind to certain dangerous cells or molecules, such as cancer cells, or plaques in blood vessels that have the potential to cause heart attacks, according to BBC News. A person would swallow ...

Bristol immunotherapy shows promise in lung cancer trial

Thu, 10/30/2014 - 13:12
By Bill Berkrot (Reuters) - Treatment of advanced squamous cell non-small cell lung cancer (NSCLC) with Bristol-Myers Squibb Co's experimental immunotherapy nivolumab led to a one-year survival rate of 41 percent in a midstage clinical trial, according to data being presented at a medical meeting. While the study called CheckMate-063 did not compare nivolumab with another drug or placebo, the ...

The HPV Vaccine's Power to Prevent Cancer

Thu, 10/30/2014 - 13:11
Anna Giuliano, a cancer researcher at Moffitt Cancer Center in Tampa, Florida, poses a question: "Let's say we have a vaccine to prevent breast or prostate cancer. Do you think we would have any pushback?"

Experts cautious over Google nanoparticle project

Wed, 10/29/2014 - 18:18
A Google project to develop nanoparticles that can detect cancer cells inside the body is a useful contribution but faces important hurdles, experts said on Wednesday. The technology could yield "another tool in our arsenal (but) in my opinion, it won't be a game-changer in terms of diagnostics," said Agnes Buzyn, president of France's National Cancer Institute (InCA). Google X Lab, a special ...

Pages